Home > Financial Ratios > WOCKHARDT

WOCKHARDT
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for WOCKHARDT
Please provide your vote to see the results

WOCKHARDT Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 272.95-45.29-29.87360.87-56.28

What is the latest Core EBITDA Growth ratio of WOCKHARDT ?

The latest Core EBITDA Growth ratio of WOCKHARDT is 272.95 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025272.95
Mar2024-45.29
Mar2023-29.87
Mar2022360.87
Mar2021-56.28

How is Core EBITDA Growth of WOCKHARDT Trending?

Years Core EBITDA Growth % Change
Mar2025 272.95
Positive
Mar2024 -45.29
Negative
Mar2023 -29.87
Negative
Mar2022 360.87
Positive
Mar2021 -56.28 -

Other Financial Ratios of WOCKHARDT


Compare Core EBITDA Growth ratio of peers of WOCKHARDT

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WOCKHARDT ₹24,408.3 Cr -1.1% -17.9% 54.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹393,383.0 Cr 2.6% -5.1% -6.4% Stock Analytics
DIVIS LABORATORIES ₹162,026.0 Cr -0.5% -10.1% 21.8% Stock Analytics
CIPLA ₹126,159.0 Cr 4.7% 4.8% -4.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,450.0 Cr 0.6% 5.2% 8.6% Stock Analytics
DR REDDYS LABORATORIES ₹104,536.0 Cr 4.3% -0.7% -11.4% Stock Analytics


WOCKHARDT Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
WOCKHARDT

-1.1%

-17.9%

54.3%

SENSEX

-0%

-2.1%

1.1%


You may also like the below Video Courses